Nong Wenqian, Zhao Anran, Wei Jinrui, Cheng Hui, Luo Xuan, Lin Cuiwu
Guangxi Colleges and Universities Key Laboratory of Applied Chemistry Technology and Resource Development, School of Chemistry & Chemical Engineer, Guangxi University Nanning 530004 China.
Department of Chemistry, Cleveland State University 2121 Euclid Avenue Cleveland OH 44115 USA.
RSC Adv. 2018 Feb 7;8(12):6231-6241. doi: 10.1039/c7ra13397a. eCollection 2018 Feb 6.
A series of benzothiazole amide derivatives were synthesized through a facile and efficient method a nucleophilic acyl substitution reaction between 2-aminobenzothiazole and various cinnamic acid compounds. The obtained products exhibited good thermal stabilities. All compounds were evaluated for their hemostatic activities using the commercially available standard drug etamsylate as a positive control. The results showed that compound Q2 had a significant partial coagulation activity, reduced capillary permeability at 5, 10 and 50 μmol L, activated thrombin activity, and a more potent platelet aggregation activity than the positive control group (etamsylate, up to 1283.9 times in the nanomole range). A molecular modeling study revealed that compound Q2 was a competitive thrombin activator. Therefore, Q2 may be a potential lead for further biological screening and for the generation of drug molecules. Moreover, the structure-activity relationship of the prepared compounds is also discussed herein.
通过一种简便高效的方法——2-氨基苯并噻唑与各种肉桂酸化合物之间的亲核酰基取代反应,合成了一系列苯并噻唑酰胺衍生物。所得产物表现出良好的热稳定性。以市售标准药物酚磺乙胺作为阳性对照,对所有化合物的止血活性进行了评估。结果表明,化合物Q2具有显著的部分凝血活性,在5、10和50 μmol/L时可降低毛细血管通透性,激活凝血酶活性,并且血小板聚集活性比阳性对照组(酚磺乙胺,在纳摩尔范围内高达1283.9倍)更强。分子模拟研究表明,化合物Q2是一种竞争性凝血酶激活剂。因此,Q2可能是进一步生物筛选和药物分子生成的潜在先导物。此外,本文还讨论了所制备化合物的构效关系。